WallStSmart

Colgate-Palmolive Company (CL)vsS&P Global Inc (SPGI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 32% more annual revenue ($20.80B vs $15.73B). SPGI leads profitability with a 30.4% profit margin vs 10.0%. SPGI appears more attractively valued with a PEG of 1.49. SPGI earns a higher WallStSmart Score of 71/100 (B).

CL

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 8.5Value: 5.3Quality: 3.3
Piotroski: 3/9

SPGI

Strong Buy

71

out of 100

Grade: B

Growth: 8.0Profit: 8.0Value: 5.7Quality: 5.5
Piotroski: 5/9Altman Z: 1.97
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLUndervalued (+16.5%)

Margin of Safety

+16.5%

Fair Value

$104.84

Current Price

$87.55

$17.29 discount

UndervaluedFair: $104.84Overvalued

Intrinsic value data unavailable for SPGI.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL3 strengths · Avg: 9.0/10
Return on EquityProfitability
36.4%10/10

Every $100 of equity generates 36 in profit

Market CapQuality
$69.90B9/10

Large-cap with strong market position

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

SPGI5 strengths · Avg: 9.0/10
Profit MarginProfitability
30.4%10/10

Keeps 30 of every $100 in revenue as profit

Operating MarginProfitability
44.3%10/10

Strong operational efficiency at 44.3%

Market CapQuality
$126.89B9/10

Large-cap with strong market position

EPS GrowthGrowth
32.5%8/10

Earnings expanding 32.5% YoY

Free Cash FlowQuality
$1.01B8/10

Generating 1.0B in free cash flow

Areas to Watch

CL4 concerns · Avg: 3.3/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

P/E RatioValuation
33.9x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
1250.7x2/10

Trading at 1250.7x book value

SPGI2 concerns · Avg: 4.0/10
P/E RatioValuation
27.1x4/10

Moderate valuation

Altman Z-ScoreHealth
1.974/10

Grey zone — moderate risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Market Cap, Operating Margin.

Bull Case : SPGI

The strongest argument for SPGI centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 30.4% and operating margin at 44.3%. Revenue growth of 10.4% demonstrates continued momentum.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Piotroski F-Score. Debt-to-equity of 147.93 is elevated, increasing financial risk.

Bear Case : SPGI

The primary concerns for SPGI are P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

CL profiles as a value stock while SPGI is a mature play — different risk/reward profiles.

SPGI carries more volatility with a beta of 1.10 — expect wider price swings.

SPGI is growing revenue faster at 10.4% — sustainability is the question.

SPGI generates stronger free cash flow (1.0B), providing more financial flexibility.

Bottom Line

SPGI scores higher overall (71/100 vs 58/100), backed by strong 30.4% margins and 10.4% revenue growth. CL offers better value entry with a 16.5% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

S&P Global Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

S&P Global Inc. is an American publicly traded corporation headquartered in Manhattan, New York City. Its primary areas of business are financial information and analytics.

Visit Website →

Want to dig deeper into these stocks?